By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Piramal Imaging 

Tegeler Strasse 6-7

  Berlin  D13353  Germany
Phone: 49-30-461-124603 Fax: n/a



Company News
Piramal Imaging Taps M2i To Manufacture And Distribute NeuraCeq™ In Ireland 12/3/2014 9:14:14 AM
Piramal Imaging Release: First US Commercial Neuraceqâ„¢ Scan For Beta-Amyloid Plaque Imaging Performed At WVU Healthcare 8/12/2014 3:00:21 PM
Research On Piramal Imaging's Neuraceq™ (Florbetaben F18 Injection) Takes Center Stage At SNMMI 6/11/2014 9:05:18 AM
Piramal Imaging Research Key Topic At Society Of Nuclear Medicine And Molecular Imaging Annual Meeting 6/9/2014 9:13:55 AM
AC Immune SA And Piramal Imaging Announce Out-Licensing Agreement For The Development Of Tau Protein Diagnostics In Alzheimer's Disease 5/12/2014 10:01:08 AM
Piramal Imaging Release: Neuraceq(™) (Florbetaben F18 Injection) Data: An Emerging Science Topic At The American Academy of Neurology Annual Meeting In Philadelphia 4/30/2014 11:10:45 AM
FDA Approves Piramal Imaging's Neuraceq™ (Florbetaben F18 Injection) For PET Imaging Of Beta-Amyloid Neuritic Plaques In The Brain 3/21/2014 6:54:16 AM
Piramal Imaging Enters Into A Strategic Partnership And Exclusive Licensing Agreement With Ci-Co Healthcare For Commercialization Of Florbetaben F18 11/20/2013 10:28:04 AM
Piramal Imaging Highlights New Data for Beta-Amyloid Imaging Agent Florbetaben F18 at EANM 2013 10/17/2013 7:29:41 AM
Piramal Imaging Provides Comments in Response to the Centers for Medicare and Medicaid Services (CMS) Proposed Coverage Decision for Beta-Amyloid Positron Emission Tomography (PET) 8/20/2013 9:29:13 AM